C07K 14/4742
Bactericidal/permeability-increasing protein [bpi]
Official title: {Bactericidal/Permeability-increasing protein [BPI]}
C07K14/4742 (Bactericidal/permeability-increasing protein [bpi]) appears on 113 US grants and 49 published applications in this corpus.
Search patents in C07K- Granted patents
- 113
- Published applications
- 49
- Assignees
- 39
- Inventors
- 102
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 14 | 0 |
| 1999 | 10 | 0 |
| 2000 | 14 | 0 |
| 2001 | 14 | 0 |
| 2002 | 10 | 9 |
| 2003 | 7 | 8 |
| 2004 | 2 | 7 |
| 2005 | 2 | 3 |
| 2006 | 3 | 4 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 3 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 2 | 0 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bactericidal/permeability increasing protein for use in a method of immunization, preferably as an adjuvant in a method of vaccination20 Jan 2026US 12,527,862 B2UniversitäT Regensburg
- Variant of a BPIFB4 protein2 Dec 2025US 12,486,308 B2Lgv1 S.R.L.
- Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein27 May 2025US 12,311,009 B2Lgv1 S.R.L.
- Variant of a BPIFB4 protein6 Feb 2024US 11,891,421 B2Lgvi S.R.L.
- Viral vector suitable for gene therapy encoding a variant of a BPIFB4 protein28 Dec 2021US 11,208,447 B2Roxiant Aps
- Bactericidal/permeability increasing protein for use in a method of immunization, preferably as an adjuvant in a method of vaccination16 Jul 2026US 2026/0199457 A1UniversitäT Regensburg
- Cxcl-bpi fusion protein and use thereof7 May 2026US 2026/0125434 A1Beijing Anjun Genetech Co., Ltd.
- Variant of a bpifb4 protein18 Jul 2024US 2024/0239850 A1Lgv1 S.R.L.
- Variant of a bpifb4 protein2 Jun 2022US 2022/0169686 A1Roxiant Aps
- Bactericidal/permeability increasing protein for use in a method of immunization, preferably as an adjuvant in a method of vaccination30 Sep 2021US 2021/0299252 A1UniversitäT Regensburg
Most cited
By later US patents
- Treatment of endotoxin-associated shock and preventation thereof using a BPI protein99US 5,171,739 AIncyte Pharmaceuticals, Inc. · 1992
- DNA encoding bactericidal/permeability-increasing proteins97US 5,198,541 ANew York University · 1993
- Treatment of endotoxin-associated shock and prevention thereof using a BPI protein91US 5,308,834 AIncyte Pharmaceuticals, Inc. · 1994
- Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders89US 5,089,274 AIncyte Pharmaceuticals, Inc. · 1992
- Recombinant, non-glycosylated bpi protein and uses thereof83US 5,334,584 AIncyte Pharamaceuticals, Inc. · 1994